In this interview CEO Sara Barrington of Verici DX - a developer of advanced clinical diagnostics for organ transplant - takes Vox Markets through yesterday's potentially transformational licensing & commercialisation agreement with life sciences giant Thermo Fisher Scientific. Explaining how the …
Hot Stocks
Stocks to Follow
Stock Market
Investing
AIM
Money
Equities
Markets
Private investor
VRCI
Verici DX
Thermo Fisher Scientific
organ transplant
Kidney